Bone marrow mononuclear cells
CMMo/CIC/2009
Phase 2 other completed
Quick answer
Bone marrow mononuclear cells for Chronic Myocardial Ischemia is a Phase 2 program (other) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Chronic Myocardial Ischemia
- Phase
- Phase 2
- Modality
- other
- Status
- completed